These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

523 related items for PubMed ID: 19010146

  • 1. Treatment of anemia in renal transplantation: impact of a stricter application of hemoglobin targets.
    Gentil MA, Pérez-Valdivia MA, González-Roncero FM, López-Mendoza M, Cabello V, Bernal G, Suñer M, Pereira P.
    Transplant Proc; 2008 Nov; 40(9):2916-8. PubMed ID: 19010146
    [Abstract] [Full Text] [Related]

  • 2. Factor deficiency in the anemia of renal transplant patients with grade III-IV chronic kidney disease: baseline results of the ARES Study.
    Gentil MA, Pérez-Valdivia MA, López-Mendoza M, Ortega F, Arias M, Gómez-Alamillo C, Campistol JM, ARES Study Group.
    Transplant Proc; 2008 Nov; 40(9):2922-4. PubMed ID: 19010148
    [Abstract] [Full Text] [Related]

  • 3. Re-establishment of erythropoietin responsiveness in end-stage renal failure following renal transplantation.
    Jeffrey RF, Kendall RG, Prabhu P, Norfolk DR, Will EJ, Davison AM.
    Clin Nephrol; 1995 Oct; 44(4):241-7. PubMed ID: 8575124
    [Abstract] [Full Text] [Related]

  • 4. [Incidence and management of anemia in renal transplantation: an observational-French study].
    Choukroun G, Deray G, Glotz D, Lebranchu Y, Dussol B, Bourbigot B, Lefrançois N, Cassuto-Viguier E, Toupance O, Hacen C, Lang P, Mazouz H, Martinez F.
    Nephrol Ther; 2008 Dec; 4(7):575-83. PubMed ID: 18672417
    [Abstract] [Full Text] [Related]

  • 5. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
    Palazzuoli A, Silverberg D, Iovine F, Capobianco S, Giannotti G, Calabrò A, Campagna SM, Nuti R.
    Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. An underappreciated problem in renal transplant recipients: anemia.
    Unal A, Sipahioglu MH, Akcakaya M, Tokgoz B, Sav T, Oymak O, Utas C.
    Transplant Proc; 2008 Jun; 40(5):1399-403. PubMed ID: 18589116
    [Abstract] [Full Text] [Related]

  • 8. Anemia in kidney transplants without erythropoietic agents: levels of erythropoietin and iron parameters.
    Florit EA, Hadad F, Rodriguez Cubillo B, De la Flor JC, Valga F, Perez Flores I, Calvo Romero N, Valero San Cecilio R, Barrientos Guzman A, Sanchez Fructuoso A.
    Transplant Proc; 2012 Nov; 44(9):2590-2. PubMed ID: 23146464
    [Abstract] [Full Text] [Related]

  • 9. Erythropoietin deficiency and relative resistance cause anaemia in post-renal transplant recipients with normal renal function.
    Nampoory MR, Johny KV, al-Hilali N, Seshadri MS, Kanagasabhapathy AS.
    Nephrol Dial Transplant; 1996 Jan; 11(1):177-81. PubMed ID: 8649630
    [Abstract] [Full Text] [Related]

  • 10. Anaemia after renal transplantation.
    Vanrenterghem Y.
    Nephrol Dial Transplant; 2004 Aug; 19 Suppl 5():V54-58. PubMed ID: 15284361
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Influence of the current management of renal transplant recipients on the prevalence of anemia and related costs.
    Gentil MA, Cabello V, Perez-Valdivia M, Lopez-Mendoza M, Gonzalez-Roncero F, Muñoz J, Bernal G, Pereira P, Rodriguez-Algarra G.
    Transplant Proc; 2005 Nov; 37(9):3823-4. PubMed ID: 16386551
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Regarding the optimal hemoglobin target range in renal anemia].
    Maurin N.
    Med Klin (Munich); 2008 Sep 15; 103(9):633-7. PubMed ID: 18813886
    [Abstract] [Full Text] [Related]

  • 18. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N, Osman-Malik Y, Frinak S, Besarab A.
    Am J Kidney Dis; 2006 Apr 15; 47(4):644-54. PubMed ID: 16564942
    [Abstract] [Full Text] [Related]

  • 19. Target level for hemoglobin correction in patients with diabetes and CKD: primary results of the Anemia Correction in Diabetes (ACORD) Study.
    Ritz E, Laville M, Bilous RW, O'Donoghue D, Scherhag A, Burger U, de Alvaro F, Anemia Correction in Diabetes Study Investigators.
    Am J Kidney Dis; 2007 Feb 15; 49(2):194-207. PubMed ID: 17261422
    [Abstract] [Full Text] [Related]

  • 20. The effect of erythropoietin on lactate, pyruvate and excess lactate under physical exercise in dialysis patients.
    Meierhenrich R, Jedicke H, Voigt A, Lange H.
    Clin Nephrol; 1996 Feb 15; 45(2):90-7. PubMed ID: 8846536
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.